- Home
- IREN vs BAX Comparison
IREN vs BAX Comparison
Compare IREN & BAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IREN | BAX |
|---|---|---|
| Founded | 2018 | 1931 |
| Country | Australia | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.0B | 13.9B |
| IPO Year | 2021 | 1994 |
Fundamental Metrics
Financial Performance| Metric | IREN | BAX |
|---|---|---|
| Price | $35.44 | $26.15 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 11 | 9 |
| Target Price | ★ $62.50 | $21.00 |
| AVG Volume (30 Days) | ★ 38.5M | 7.2M |
| Earning Date | 05-07-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 0.24% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.21 |
| Revenue | $707,007,000.00 | ★ $11,244,000,000.00 |
| Revenue This Year | $104.58 | $1.96 |
| Revenue Next Year | $200.20 | $2.22 |
| P/E Ratio | ★ N/A | $123.48 |
| Revenue Growth | ★ 41.11 | 5.72 |
| 52 Week Low | $25.31 | $15.73 |
| 52 Week High | $76.87 | $30.00 |
Technical Indicators
Market Signals| Indicator | IREN | BAX |
|---|---|---|
| Relative Strength Index (RSI) | 42.86 | 51.73 |
| Support Level | $31.31 | $25.75 |
| Resistance Level | $44.60 | $30.00 |
| Average True Range (ATR) | 2.77 | 0.63 |
| MACD | -0.25 | -0.29 |
| Stochastic Oscillator | 3.56 | 7.06 |
Price Performance
Historical ComparisonAbout IREN Iris Energy Limited
IREN owns data centers powered by renewable energy in Canada and the US for bitcoin mining and AI cloud infrastructure. The company is in the process of converting its existing bitcoin capacity for AI purposes and securing new power and land supply to expand its data center operation. IREN works closely with industry leaders in AI, such as Microsoft, to support their cloud infrastructure ambitions.
About BAX Baxter International Inc.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.